Regulation:
OAR 411-054-0055 (2) Systems: Medication Administration
(2) MEDICATION ADMINISTRATION. An accurate Medication Administration Record (MAR) must be kept of all medications, including over-the-counter medications that are ordered by a legally recognized prescriber and are administered by the facility.(a) Documentation of the MAR must be completed using one of the following processes. An alternative process may be used only with a written exception from the Department.(A) The MAR may be signed as the medications are set-up or poured. Medications must not be set-up in advance for more than one administration time. If a medicine cup or other individual container is used to set-up the medications, it must be placed in a closed compartment labeled with the resident's name. Changes to the MAR that occur after the medication is delivered, must be documented by the same staff person who administered the medication.(B) The facility may choose to sign the MAR after the medication is administered to a specific resident and prior to the next resident-specific medication or treatment.(b) MEDICATION RECORD. At minimum, the medication record for each resident that the facility administers medications to, must include:(A) Current month, day and year.(B) Name of medications, reason for use, dosage, route and date and time given.(C) Any medication specific instructions, if applicable (e.g., significant side effects, time sensitive dosage, when to call the prescriber or nurse).(D) Resident allergies and sensitivities, if any.(E) Resident specific parameters and instructions for p.r.n. medications.(F) Initials of the person administering the medication.
Inspection Findings:
Based on interview and record review, it was determined the facility failed to ensure resident-specific parameters and instructions were included for PRN medications and failed to ensure the MAR included the correct dosage of medication for 2 of 3 sampled residents (#s 1 and 2) whose MARs were reviewed. Findings include, but are not limited to:
1. Resident 2 moved into the community in 12/2012 with diagnoses including psoriatic arthritis mutilans and chronic obstructive pulmonary disease.
The resident’s MAR, dated 10/01/25 to 10/27/25, was reviewed, and the following orders were noted:
a. The resident had orders for two PRN medications for pain that did not have parameters for order of administration by unlicensed staff:
* Acetaminophen 500 mg, two tablets every six hours; and
* Hydromorphone HCl 4 mg tablet every four hours.
b. The resident had three orders for PRN medications for constipation that did not have parameters for order of administration by unlicensed staff:
* PEG 3350 powder 238 gm, mix 17 g in liquid;
* Senna 8.6 mg, one tablet daily; and
* Senna 8.6 mg, two tablets if no bowel movement in three days, not to exceed two tablets per day.
In an interview with Staff 15 (MT) on 10/28/25 at 2:35 pm, s/he stated, “I would probably give the Senna,” if the resident complained of constipation, “but actually, I would text the nurse just to make sure.”
The need to ensure resident-specific parameters and instructions for PRN medications were included on the MAR was reviewed with Staff 1 (Executive Director), Staff 2 (Director of Health Services), Staff 6 (Regional Operations Specialist), Staff 7 (Regional Nurse), and Staff 8 (Regional Director of Operations) on 10/29/25 at 2:30 pm. They acknowledged the findings.
2. Resident 1 moved into the community in 05/2025 with diagnoses including dementia and constipation.
The resident’s MAR, dated 10/01/25 to 10/27/25, was reviewed, and the following orders were noted:
a. The resident had orders for two PRN medications for pain that lacked parameters for order of administration by unlicensed staff:
* Acetaminophen 325 mg two tablets daily as needed for pain; and
* Morphine sulfate 20 mg/ml 0.25 to 0.5 ml every four hours as needed for pain.
b. The resident had two orders for PRN medications for constipation that lacked parameters for order of administration by unlicensed staff:
* Bisacodyl rectal suppository 10 mg rectally every 24 hours as needed for constipation; and
* Polyethylene glycol 17 grams as needed for bowel care.
c. The following medications lacked the specific dosage to administer:
* Morphine sulfate 20 mg/ml 0.25 to 0.5 ml every four hours as needed for pain; and
* Lorazepam 0.5 to 1 mg every four hours as needed for anxiety or shortness of breath.
In an interview on 10/28/25 at 11:00 am, Staff 2 (Director of Health Services) confirmed the lack of PRN parameters for the pain and bowel medications, as well as the ranges of the dosage of medications on the October MAR.
The need to ensure resident-specific parameters and instructions for PRN medications were included on the MAR and all medications had the correct dosage to administer was reviewed with Staff 1 (Executive Director), Staff 2, Staff 6 (Regional Operations Specialist), Staff 7 (Regional Nurse), and Staff 8 (Regional Director of Operations) on 10/29/25 at 1:55 pm. They acknowledged the findings.
Plan of Correction:
1. All errors in parameters related to the bowel meds and to pain meds have been fixed with Resident 1 and Resident 2.
2. The Med Techs will be educated on clear parameters for PRN meds and education if an order is found to not have clear parameters. The Registered Nurse will review PRN orders for accurate Parpameters in MARS as a part of the new order review process.
3. We will audit new PRN medication orders M-F during clinical meetings for 4 weeks, if no issues are found we will audit PRNs monthly as part of our Quality Assurance process.
4. Registered Nurse, Resident Care Coordinator, and Administrator.